z-logo
open-access-imgOpen Access
ERBB4 Confers Risk for Polycystic Ovary Syndrome in Han Chinese
Author(s) -
Ying Peng,
Wei Zhang,
Ping Yang,
Ye Tian,
Shizhen Su,
Changming Zhang,
ZiJiang Chen,
Han Zhao
Publication year - 2017
Publication title -
scientific reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.24
H-Index - 213
ISSN - 2045-2322
DOI - 10.1038/srep42000
Subject(s) - polycystic ovary , han chinese , ovary , medicine , biology , gynecology , bioinformatics , genetics , gene , insulin resistance , obesity , single nucleotide polymorphism , genotype
A recent genome-wide association study (GWAS) of polycystic ovary syndrome (PCOS) in European cohorts has identified six susceptibility loci mapping to 11q22.1 ( YAP1 ), 2p21 ( THADA ), 11p14.1 ( FSHB ), 2q34 ( ERBB4 ), 12q21.2 ( KRR1 ), and 5q31.1 ( RAD50 ). The loci of 11q22.1, 2p21 and 11p14.1 have been confirmed to be associated with PCOS in Chinese; whereas the other three new loci (2q34, 12q21.2, and 5q31.1) still need to be evaluated in Chinese. This study was aimed to determine if the three new loci identified in European PCOS also confer risks for PCOS in Han Chinese. We performed a case-control genetic association study comprising 1500 PCOS cases and 1220 age-matched control subjects. Marker SNPs rs1351592 (2q34, ERBB4 ), rs1275468 (12q21.2, KRR1 ) and rs13164856 (5q31.1, RAD50 ) were genotyped using TaqMan-MGB probe assay. Genotyping analysis showed the allele frequency of rs1351592 in gene ERBB4 was significantly different ( P  = 1.05E-03) between PCOS cases and control group, and remained significant even after BMI adjustment ( P adjusted  = 2.09E-04). However, the allele frequencies of the other two risk variants, rs1275468 (12q21.2, KRR1 ) and rs13164856 (5q31.1, RAD50 ), were not significantly different in the replication cohort. Our results demonstrate that ERBB4 , with the strongest association in European PCOS, also confers risk for PCOS in Han Chinese.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here